Search results for " metastasis"

showing 10 items of 623 documents

The Epithelial Mesenchymal Transition Process in Wilms Tumor

2011

Background Until now, only a few mouse-transplanted human tumors or experimental Wilms tumor (WT) cell lines have been described. The aim of this study was to show the biological behavior, including histology, immunohistochemistry (IHC), and molecular biology, of a WT including the original tumor and metastasis transferred into nude mice and followed for successive generations in xenografts. Methods A WT metastasis was xenotransplanted into nude mice and the mice was monitored for 7 passages over a period of 29 months; the original neoplasm was comparatively studied. The morphology was evaluated by optical and electron microscopy. The protein expression was analyzed by immunohistochemistry …

Epithelial-Mesenchymal TransitionHistologyDNA Mutational AnalysisMice NudeCell Growth ProcessesWilms TumorBone and BonesPathology and Forensic MedicineMetastasisMicemedicineAnimalsHumansEpithelial–mesenchymal transitionNeoplasm MetastasisOncogene ProteinsN-Myc Proto-Oncogene ProteinTissue microarrayChemistryMesenchymal stem cellNuclear ProteinsEye Diseases HereditaryWilms' tumorHistologyStriated muscle cell differentiationMicroarray Analysismedicine.diseaseImmunohistochemistryXenograft Model Antitumor AssaysKidney NeoplasmsWnt ProteinsRadiusMedical Laboratory TechnologyMutationCancer researchImmunohistochemistrySignal TransductionApplied Immunohistochemistry & Molecular Morphology
researchProduct

Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion

2022

Osteosarcoma (OS) is the most common primary bone tumor mainly occurring in young adults and derived from primitive bone-forming mesenchyme. OS develops in an intricate tumor microenvironment (TME) where cellular function regulated by microRNAs (miRNAs) may affect communication between OS cells and the surrounding TME. Therefore, miRNAs are considered potential therapeutic targets in cancer and one of the goals of research is to accurately define a specific signature of a miRNAs, which could reflect the phenotype of a particular tumor, such as OS. Through NGS approach, we previously found a specific molecular profile of miRNAs in OS and discovered 8 novel miRNAs. Among these, we deepen our …

Epithelial-Mesenchymal TransitionQH301-705.5MAP Kinase Signaling SystemEMT proteinBone NeoplasmsArticleCatalysisCell LineInorganic ChemistryCell Line TumorHuman Umbilical Vein Endothelial CellsmetastasisHumansNeoplasm InvasivenessBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyOsteosarcomaOsteoblastsmicroRNANeovascularization PathologicOrganic ChemistryEMT proteinstumor angiogenesisGeneral MedicinemicroRNAsComputer Science ApplicationsGene Expression Regulation NeoplasticChemistryosteosarcoma; microRNAs; tumor angiogenesis; metastasis; EMT proteinsmetastasitumor angiogenesiInternational Journal of Molecular Sciences
researchProduct

Breakthrough Pain (BTP) in Opioid-Tolerant Cancer Patients: A Pan-European Open-Label Multicentre Study with Fentanyl Buccal Tablet (FBT)

2012

ABSTRACT BTP, a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain, is a common problem in cancer patients. FBT is indicated for the treatment of BTP in adults with cancer already receiving maintenance opioid therapy for chronic cancer pain and should be titrated to an effective dose that provides adequate analgesia and minimises undesirable events. In this study, patients entered a screening period and were randomized during an open-label titration period to a starting FBT dose of 100 µg (group A) or 200 µg (group B) to identify the FBT effective dose and then treated in an open-label period (for 8 BTP episodes). Patients' inclusion followed…

Exacerbationbusiness.industryBreakthrough PainRectumBone metastasisHematologymedicine.diseaseEffective dose (pharmacology)Group Bmedicine.anatomical_structureOncologyOpioidAnesthesiaFentanyl Buccal Tabletmedicinebusinessmedicine.drugAnnals of Oncology
researchProduct

A systematic review on external ear melanoma

2014

Summary Background External ear melanoma accounts for only 1% of all cutaneous melanomas, and data on its optimal management and prognosis are limited. Aim We aim to review the literature on external ear melanoma to guide surgeons in the treatment of this uncommon and peculiar pathology. Materials and methods A systematic review of English language studies on ear melanoma published from 1993 to 2013 was performed using the PubMed electronic database. Data on epidemiology, oncological treatment (tumor resection and regional lymph nodes management), and reconstruction were extrapolated from selected papers. Results The total number of patients was 858 (30 studies). The helix was the most comm…

External earmedicine.medical_specialtySkin NeoplasmsPrognosiSentinel lymph nodeSettore MED/19 - Chirurgia PlasticaSurgical FlapsBreslow ThicknessEpidemiologyBiopsymedicineHumansReconstructive Surgical ProcedureSkin NeoplasmStage (cooking)Ear ExternalMelanomaEar NeoplasmsNeoplasm Stagingmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaLymphatic MetastasiPlastic Surgery Proceduresmedicine.diseasePrognosisOptimal managementSuperficial spreading melanomaSurgeryEar NeoplasmSurgical FlapLymphatic MetastasisSurgeryNeoplasm Recurrence LocalbusinessEar melanomaMelanoma treatmentHuman
researchProduct

2021

Bone is a frequent site of metastases, being typically associated with a short-term prognosis in affected patients. Photodynamic therapy (PDT) emerges as a promising alternative treatment for controlling malignant disease that can directly target interstitial metastatic lesions. The aim of this study was to assess the effect induced by PDT treatment on both primary (giant cell bone tumor) and human bone metastatic cancer cell lines (derived from a primary invasive ductal breast carcinoma and renal carcinoma). After 24 h post light delivery (blue light-wavelength 436 nm) with 5-aminolevulinic acid, the effect on cellular migration, viability, apoptosis, and senescence were assessed. Our resu…

General Immunology and Microbiologymedicine.medical_treatmentBone metastasisPhotodynamic therapyCell migrationBiologymedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyMetastasisBreast cancerApoptosisGiant cellmedicineCancer researchFragmentation (cell biology)General Agricultural and Biological SciencesBiology
researchProduct

Genetic and epigenetic alterations as hallmarks of the intricate road to cancer.

2003

Despite the clonal origin of most tumors, their tremendous heterogeneity suggests that cancer progression springs from the combined forces of both genetic and epigenetic events, which produce variant clonal populations, together with the selective pressures of the microenvironment, which promote growth and, perhaps, dissemination of variants with a specific set of characteristics. Although the importance of genetic mutations in cancer has long been recognized, the role of epigenetic events has been suggested more recently. This review focuses on the genetic and epigenetic molecular mechanisms involved in cancer onset and progression, and discusses the possibility of new strategies in the de…

GeneticsCancer ResearchCell CycleCancerBiologymedicine.diseasemedicine.disease_causeNeoplasmsMutationGeneticsmedicineDisease ProgressionHumansEpigeneticsNeoplasm MetastasisCarcinogenesisMolecular BiologyOncogene
researchProduct

Cancer stem cells – old concepts, new insights

2008

Cancer has long been viewed as an exclusively genetic disorder. The model of carcinogenesis, postulated by Nowell and Vogelstein, describes the formation of a tumor by the sequential accumulation of mutations in oncogenes and tumor suppressor genes. In this model, tumors are thought to consist of a heterogeneous population of cells that continue to acquire new mutations, resulting in a highly dynamic process, with clones that out compete others due to increased proliferative or survival capacity. However, novel insights in cancer stem cell research suggest another layer of complexity in the process of malignant transformation and preservation. It has been reported that only a small fraction…

GeneticsCell typeCancerOncogenesCell BiologyBiologymedicine.diseasemedicine.disease_causeMalignant transformationTransplantationMiceCancer stem cellHematologic NeoplasmsNeoplasmsGenetic modelCancer cellNeoplastic Stem CellsmedicineCancer researchAnimalsHumansNeoplasm MetastasisCarcinogenesisMolecular BiologyCell Death & Differentiation
researchProduct

Factors that influence treatment delay in patients with colorectal cancer

2016

// Irene Zarcos-Pedrinaci 1, 11 , Alberto Fernandez-Lopez 2 , Teresa Tellez 1, 11 , Francisco Rivas-Ruiz 1, 11 , Antonio Rueda A 3, 11 , Maria Manuela Morales Suarez-Varela 4 , Eduardo Briones 5 , Marisa Bare 6, 11 , Antonio Escobar 7, 11 , Cristina Sarasqueta 8, 11 , Nerea Fernandez de Larrea 9, 11 , Urko Aguirre 10, 11 , Jose Maria Quintana 10, 11 , Maximino Redondo 1, 11 and On Behalf of the CARESS-CCR Study Group 1 Research Unit, Agencia Sanitaria Costa del Sol, Marbella, Spain 2 Servicio de Cirugia, Agencia Sanitaria Costa del Sol, Marbella, Spain 3 Servicio de Oncologia Medica, Agencia Sanitaria Costa del Sol, Marbella, Spain 4 Unit of Public Health, Hygiene and Environmental Health, …

GerontologyMaleDelayed Diagnosis0302 clinical medicineHygieneRisk FactorsEpidemiologyCancer screeningOdds RatioNeoplasm MetastasisProspective cohort studyCàncerColorectalmedia_commonCancercolorectaleducationDelaytreatmentMiddle AgedOncology030220 oncology & carcinogenesisPopulation study030211 gastroenterology & hepatologyFemaleColorectal Neoplasmsmedicine.medical_specialtydelaymedia_common.quotation_subjectEducationTime-to-Treatment03 medical and health sciencesmedicineBiomarkers TumorcancerHumansRecte MalaltiesPreventive healthcareAgedNeoplasm Stagingbusiness.industryPublic healthTreatmentSocioeconomic FactorsFamily medicineClinical Research PaperNeoplasm GradingbusinessFactor Analysis StatisticalEnvironmental epidemiology
researchProduct

Treatment of esophageal cancer in inoperable elderly patients: our experience

2009

The esophagus carcinoma has an incidence rate of 3–4 new cases per 100,000 inhabitants, per year, with a male/female ratio of 3:1 and with a low incidence between the VI–VII decade of life. In Italy, the incidence rate equals 2,000 new cases/year with a mortality rate of 3–5/100,000 inhabitants.

GerontologyPediatricsmedicine.medical_specialtybusiness.industryMortality rateIncidence (epidemiology)AchalasiaEsophageal cancermedicine.diseaseHepatic metastasisSettore MED/18 - Chirurgia GeneraleEsophagus Carcinomaederly patients cancer esofagealMeeting AbstractmedicineGeriatrics and GerontologyReflux esophagitisbusinessEsophagitisBMC Geriatrics
researchProduct

Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study.

2019

Objective: To report preliminary findings of a phase II study exploring the clinical outcomes of moderate hypofractionated radiotherapy performed with helical tomotherapy (HT) using computed tomography–magnetic resonance imaging–based planning for localized prostate cancer. Methods: The phase II prospective study received ethics approval from our institutional ethics committee. A dose of 60 Gy/20 fractions for low–intermediate risk prostate cancer by means of HT was explored. Primary endpoints of the study were acute and late gastrointestinal (GI) and genitourinary (GU) toxicities. Secondary endpoints were quality of life and biochemical-free survival. Results: A total of 35 patients were i…

Hypofractionated RadiotherapyMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmenttomotherapyPhases of clinical researchTomotherapy030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicinePreliminary reportProstatemedicineBiomarkers TumorHumansProspective StudiesNeoplasm MetastasisProspective cohort studyRadiometryProstate hypofractionation tomotherapyAgedNeoplasm StagingAged 80 and overhypofractionationbusiness.industryRadiotherapy Planning Computer-AssistedProstateProstatic NeoplasmsGeneral MedicineMiddle Agedmedicine.diseasehypofractionation; Prostate; tomotherapymedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisQuality of LifeObservational studyRadiation Dose HypofractionationRadiologyRadiotherapy Intensity-ModulatedbusinessFollow-Up StudiesTumori
researchProduct